Adlai Nortye Announces First Patient Dosed in Phase Ia Clinical Trial of AN2025 and AN0025 in Combination with atezolizumab for Advanced Solid Tumors
- Written by: ACN Newswire - Press Releases
.
Selling a Small Business in Australia: Understanding the Capital Gains Tax Concessions
For many Australian business owners, selling a business represents the reward for years—sometimes decades—of hard work. Unlike employees who may bu...
Australian businesses lean into global strategic partnerships (GCCs) for next wave of outsourcing
The Australian corporate landscape is undergoing a fundamental transformation in how it sources talent and innovation. While businesses have traditi...
The New Pressure Gap Crushing Small Businesses
Starting any business and making it prosper is a major undertaking. Part of the challenge is managing the uncertainty, but the financial pressures o...
Click Frenzy returns with a free EOFY sale event for retailers this month
New owners Gabby and Hezi Leibovich bring back Australia’s leading ecommerce sales event with Australia Post as Major Sponsor Click Frenzy is ...
The 95 Per Cent Failure Rate Is Not An AI Problem
Most Australian SMEs I speak with are already having a go at AI. Some are running formal pilots, others have a team member quietly experimenting o...
New AR tech helping to solve field service skills crisis
AI-enabled augmented reality (AR) smart glasses are emerging as a new practical solution to fill a shortage of field service technicians maintaini...